Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: A randomized, controlled trial

Sexually Transmitted Diseases

Volumn 30, Issue 1, 2003, Pages 49-56

  Schillinger, Julia A ^a   Kissinger, Patricia ^a   Calvet, Helene ^a   Whittington, William L H ^a   Ransom, Ray L ^a   Sternberg, Maya R ^a   Berman, Stuart M ^a   Kent, Charlotte K ^a   Martin, David H ^a   Oh, M Kim ^a   Handsfield, H Hunter ^a   Bolan, Gail ^a   Markowitz, Lauri E ^a   Fortenberry, J Dennis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALGORITHM; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ECTOPIC PREGNANCY; FEMALE; FEMALE INFERTILITY; HIGH RISK POPULATION; HUMAN; INFECTION RISK; LIGASE CHAIN REACTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; REINFECTION; RISK ASSESSMENT; RISK FACTOR; SEXUALITY; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

EID: 0037227245     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200301000-00011     Document Type: Article

References (27)

1. Division of STD Prevention. Sexually transmitted disease surveillance, 1999. Department of Health and Human Services, Atlanta: Centers for Disease Control and Prevention (CDC), September 1999.
2. Groseclose SL, Zaidi AA, DeLisle SJ, Levine WC, St Louis ME. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999; 26:339-344.
3. Xu F, Schillinger JA, Markowitz LE, Sternberg MR, Aubin MR, St Louis ME. Repeat Chlamydia trachomatis infection in women: analysis through a surveillance case registry in Washington State, 1993-1998. Am J Epidemiol 2000; 152:1164-1170.
4. Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001; 28:117-123.
5. Fortenberry JD, Brizendine EJ, Katz BP, Wools KK, Blythe MJ, Orr DP. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis 1999; 26:26-32.
6. Blythe MJ, Katz BP, Batteiger BE, Ganser JA, Jones RB. Recurrent genitourinary chlamydial infections in sexually active female adolescents. J Pediatr 1992; 121:487-493.
7. Sellors JW, Mahony JB, Chernesky MA, Rath DJ. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis. Fertil Steril 1988; 49:451-457.
8. Brunham RC, Maclean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985; 152:1275-1282.
9. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, MacKenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176:103-107.
10. Egger M, Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316:1776-1780.
11. Rein DB, Kassler WJ, Irwin KL, Rabiee L. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol 2000; 95:397-402.
12. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327:921-925.
13. Macke BA, Keenan HA, Kassler WJ. Partner notification strategies for sexually transmitted diseases. Sex Transm Dis 1998; 25:329-330.
14. Oh MK, Boker JR, Genuardi FJ, Cloud GA, Reynolds J, Hodgens JB. Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis cases. J Adolesc Health 1996; 18:4-9.
15. Hammer G, Kent C, Courtney J, Kohn R, Klausner J. Does patient-delivered partner therapy decrease sexually transmitted disease reinfection? [abstract]. Presented at the National STD Prevention Conference, Milwaukee, Wisconsin, 2000.
16. Kissinger P, Brown R, Reed K, et al. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect 1998; 74:331-333.
17. Golden MR, Whittington WLH, Gorbach PM, Coronado N, Boyd MA, Holmes KK. Partner notification for chlamydial infections among private sector clinicians in Seattle-King County: a clinician and patient survey. Sex Transm Dis 1999; 26:543-547.
18. Brackbill RM, Sternberg MR, Fishbein M. Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect 1999; 31:10-15.
19. Deleted in proof.
20. Ramstedt K, Forssman L, Johannisson G. Contact tracing in the control of genital Chlamydia trachomatis infection. Int J STD AIDS 1991; 2:116-118.
21. Pocock SJ. Clinical Trials: A Practical Approach. New York: John Wiley & Sons Ltd., 1983.
22. Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998; 177:417-424.
23. Golden MR, Whittington WL, Handsfield HH, et al. Partner management for gonococcal and chlamydial infection: expansion of public health services to the private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis 2001; 28:658-665.
24. Fortenberry JD. Health care seeking behaviors related to sexually transmitted diseases among adolescents. Am J Public Health 1997; 87:417-420.
25. Bachmann LH, Stephens J, Richey CM, Hook EW 3rd. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis 1999; 26:272-278.
26. van de Laar MJ, Termorshuizen F, van den Hoek A. Partner referral by patients with gonorrhea and chlamydial infection. Case-finding observations. Sex Transm Dis 1997; 24:334-342.
27. Fortenberry JD, Brizendine EJ, Katz BP, Orr DP. The role of self-efficacy and relationship quality in partner notification by adolescents with sexually transmitted infections. Arch Pediatr Adolesc Med 2002; 156:1133-1137.